Skip to search formSkip to main contentSkip to account menu

dzherelo

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Plant Preparations

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Impact of Adjunct Immunotherapy with Multi-herbal Supplement Dzherelo (Immunoxel) on Treatment Outcomes in End-stage TB/HIV Patients
Prognosis for TB/HIV co-infection is very unfavourable. In terminally-ill patients treatment options are often limited to… 
2009
2009
Treatment of cavitary and infiltrating pulmonary tuberculosis with and without the immunomodulator Dzherelo.
An open-label, 60-day trial was conducted in 75 newly diagnosed tuberculosis (TB) patients to assess the adjunctive effect of the… 
2009
2009
Changes in CD4+ T-cells and HIV RNA resulting from combination of anti-TB therapy with Dzherelo in TB/HIV dually infected patients
The open-label, phase II clinical trial of antituberculosis therapy (ATT) with or without oral immunomodulator Dzherelo… 
2009
2009
Effect of Immunomodulating Adjuvant Dzherelo (Immunoxel) in HIV Infected Patients Receiving Standard Antiretroviral Therapy
Open-label, matched-case, comparative trial was conducted in 40 HIV-infected patients to evaluate the adjunct effect of Dzherelo… 
2009
2009
Efficacy and safety of phytoconcentrate Dzherelo (Immunoxel) in treatment of patients with multi-drug resistant TB (MDR-TB) in comparison to standard chemotherapy.
2009
2009
Adjunct Immunotherapy of Tuberculosis in Drug-Resistant TB and TB / HIV Co-Infected Patients
Open-label, salvage anti-tuberculosis therapy (ATT) combined with DZHERELO (IMMUNOXEL), SVITANOK, and LIZORM – overthe-counter… 
2008
2008
Effect of oral immunomodulator Dzherelo in TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOTS.
2008
2008
Cytokine profiles of HIV patients with pulmonary tuberculosis resulting from adjunct immunotherapy with herbal phytoconcentrates Dzherelo and Anemin.
2007
2007
Open label trial of adjuvant immunotherapy with Dzherelo, Svitanok, and Lizorm, in MDR-TB, XDR-TB and TB/HIV co-infected patients receiving anti-tuberculosis therapy under DOT
Open label trial of anti-tuberculosis therapy (ATT) combined with oral immunomodulators derived from medicinal plants, Dzherelo… 
2002
2002
[Phytoconcentrates "dzherelo" and "lizorm" in therapy of autoimmune thyroiditis].
Treatment of patients with autoimmune thyroiditis with phytoconcentrates dzherelo and lizorm has been shown to improve the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)